Author details

Full Name

Pieter W Kamphuisen

Affiliation

ORCID

Career Start Year

1998

Papers

231

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36846646	Treatment and prevention of cancer-associated thrombosis in the Netherlands: A national survey.		2023
36841648	Platelet RNA sequencing for cancer screening inÂ patients with unprovoked venous thromboembolism: aÂ prospective cohort study.	J Thromb Haemost	2023
37080574	Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.		2023
37269716	Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer.		2023
37481074	Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study.		2023
36846648	Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.		2023
34662498	Growth differentiation factor-15 for prediction of bleeding in cancer patients.	Journal of Thrombosis and Haemostasis	2022
36271456	ISTH guidelines for antithrombotic treatment in COVID-19: Comment from Huisman et al.	Journal of Thrombosis and Haemostasis	2022
34455706	Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.	Journal of Thrombosis and Haemostasis	2021
34293538	Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19.	Thrombosis Research	2021
33537547	Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study.	Research and Practice in Thrombosis and Haemostasis	2021
33501757	Pulmonary embolism at autopsy in cancer patients.	Journal of Thrombosis and Haemostasis	2021
33306241	Clinical history of cancer-associated splanchnic vein thrombosis.	Journal of Thrombosis and Haemostasis	2021
33212381	Carotid plaque composition in persons with hemophilia: An explorative study with multi-contrast MRI.	Thrombosis Research	2021
34409743	Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer.	J Thromb Haemost	2021
33104795	Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.	Blood Adv	2020
32424862	Thromboembolic and bleeding complications in patients with oesophageal cancer.	Br J Surg	2020
32396939	Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.	Blood	2020
31986475	Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.	Thrombosis Research	2020
32458002	Anticoagulant activity of edoxaban in patients with cirrhosis.	Blood	2020
30731492	Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.	Thrombosis and Haemostasis	2019
31597460	Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.	Circulation	2019
30606788	The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.	Haematologica	2019
29943142	[18]F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques.	J Nucl Cardiol	2019
30634165	Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly.	Thrombosis Research	2019
30609442	Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis.	Thrombosis and Haemostasis	2019
31402557	Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.	Journal of Thrombosis and Haemostasis	2019
29112547	European guidelines on perioperative venous thromboembolism prophylaxis: Chronic treatments with antiplatelet agents.	European Journal of Anaesthesiology	2018
30265883	Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism.	Thrombosis Research	2018
30369307	Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial.	Journal of the American Heart Association	2018
29573330	Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.	Journal of Thrombosis and Haemostasis	2018
29618162	Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.	Thrombosis and Haemostasis	2018
29656167	Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.	Thrombosis Research	2018
29125695	Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm.	Journal of Thrombosis and Haemostasis	2018
28226257	Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.	Thrombosis Research	2017
28693366	Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.	N Engl J Med	2017
28688113	Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score.	Journal of Thrombosis and Haemostasis	2017
28550192	Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.	Haematologica	2017
28429651	Time to improve statin prescription guidelines in low-risk patients?	European Journal of Preventive Cardiology	2017
28761749	Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.	ESMO Open	2017
28376316	Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer.	Thrombosis Research	2017
28569924	Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.	Thrombosis and Haemostasis	2017
28697983	Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles.	J Clin Lipidol	2017
27071821	Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.	European Heart Journal	2017
28231936	Effect of Linagliptin onÂ Arterial F-Fluorodeoxyglucose Positron Emission Tomography Uptake: A Randomized Controlled Trial (RELEASE).	Journal of the American College of Cardiology	2017
28029329	Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.	Journal of Clinical Oncology	2017
28244635	Effect of linagliptin on pulse wave velocity in early type 2 diabetes: A randomized, double-blind, controlled 26-week trial (RELEASE).	Diabetes, Obesity and Metabolism	2017
27815967	A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients.	Thromb Res	2016
27067963	Long-term arterial complications of chemotherapy in patients with cancer.	Thrombosis Research	2016
27281773	Arterial Stiffness Is Positively Associated With 18F-fluorodeoxyglucose Positron Emission Tomography-Assessed Subclinical Vascular Inflammation in People With Early Type 2 Diabetes.	Diabetes Care	2016